• Sonuç bulunamadı

ESC guidelines on diabetes, ECHO-TR trial, and more

N/A
N/A
Protected

Academic year: 2021

Share "ESC guidelines on diabetes, ECHO-TR trial, and more"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Editorial

ESC guidelines on diabetes, ECHO-TR trial, and more

213

In this issue, we have a very good review of the new European Society of Cardiology Guide-lines on diabetes; prediabetes, and cardiovascular diseases written by Prof. Fras, from Slove-nia. He focuses on whether the new guidelines are a truly strong base for a major paradigm shift in clinical practice.

Another review comes to us from Romania. Grigoras et al. provide an update on perivascu-lar adipose tissue (PVAT) in cardiovascuperivascu-lar diseases. They summarize the current knowledge and discuss the role of PVAT as a major contributing factor in the pathogenesis of ischemic coronary disease, hypertension, obesity, and diabetes mellitus.

Li Zhao, from China, reports on the alleviation of oxidative stress and mitochondrial dys-function with trimetazidine and coenzyme Q10 in cisplatin-induced cardiotoxicity in isolated rat cardiomyocytes.

Tunçez et al., from Turkey, compare the pleiotrophic effects of atorvastatin and rosuvas-tatin on the serum levels of endocan, chemerin, and galectin-3 in patients with acute myocar-dial infarction.

Adding a new factor to the etiopathogenesis of coronary artery ectasia (CAE), Özkan et al., from Turkey, analyze the association between low serum adropin level and isolated CAE.

Ning et al., from China, examine big endothelin-1 as a clinical marker for ventricular tach-yarrhythmia in post-infarction left ventricular aneurysm.

In a special trial that included 31centers from across Turkey, Şafak et al. present “Normal echocardiographic measurements in a Turkish population: The Healthy Heart ECHO-TR Trial.” This study will be helpful to echocardiographers in their clinical practice.

In addition, we have interesting case reports, letters, and e-pages. I hope this issue will be of interest to our readers.

Prof. Dr. Çetin Erol Editor-in-Chief Ankara-Turkey

©Copyright 2019 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com DOI:10.14744/AnatolJCardiol.2019.11

Address for Correspondence: Prof. Dr. Çetin Erol, Ankara Üniversitesi Tıp Fakültesi, İbn-i Sina Hastanesi, Kardiyoloji Anabilim Dalı, Ankara, Türkiye

Referanslar

Benzer Belgeler

The blood glucose level must be regularly tested in a pregnant women with gestational diabetes, compliance to diet or therapy with OAD agent or insulin must be monitored, and the

 The proposed HPLC method was applied to the urine of normal (n = 13) and diabetic and hyp ertension patients (n = 80), and significant increases in D-lactate excreted into urine

factors contributing to development of atherosclerosis are chronic and systemic inflammation, systemic treatments, smoking habit, obesity, HT, DM, hyperlipidemia, and

The most important novelty of the 2018 Hypertension Guide- lines of the European Society of Cardiology and the European Society of Hypertension (ESC/ESH) (1) is the decision to

This effectively means that metformin stays as the first-line drug in patients with T2DM without CVD, and in patients at moderate CV risk, while in patients at high/very-high CV

In this case control study, we analyzed functional TGFβ1 polymorphisms with TGFβ1 serum levels and ADAMTS4 serum levels through coronary artery disease and healty subjects..

Objectives: We evaluated the impact of diabetes mellitus (DM) and/or coronary artery disease (CAD) on cardiovas- cular endpoints in a cohort of hypertensive patients.. Study

Renal blood flow (RBF), urinar output rate, creatinine clearence and urinary excretion of creatinine , protein, glucose, potassium, sodium and phosphorus excretions in diabetic